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Abstract
The human chr15q11-q13 imprinted cluster is linked to several disorders, including Prader–Willi (PWS) and Angelman (AS)
syndromes. Recently, disease modeling approaches based on induced pluripotent stem cells (iPSCs) have been used to study
these syndromes. A concern regarding the use of these cells for imprinted disease modeling is the numerous imprinting
defects found in many iPSCs. Here, by reprogramming skin fibroblasts from a control and AS individuals, we generated
several iPSC lines and addressed the stability of imprinting status across the PWS/AS domain.We focused on three important
regulatory DNA elements which are all differentially methylated regions (DMRs), methylated on the maternal allele: the
PWS imprinting center (PWS-IC), which is a germline DMR and the somatic NDN and MKRN3 DMRs, hierarchically controlled
by PWS-IC. Normal PWS-IC methylation pattern was maintained in most iPSC lines; however, loss of maternal methylation
in one out of five control iPSC lines resulted in a monoallelic to biallelic switch for many imprinted genes in this domain.
Surprisingly,MKRN3 DMR was found aberrantly hypermethylated in all control and AS iPSCs, regardless of the methylation
status of the PWS-IC master regulator. This suggests a loss of hierarchical control of imprinting at PWS/AS region. We
confirmed these results in established iPSC lines derived using different reprogramming procedures. Overall, we show that
hierarchy of imprinting control in donor cellsmight not apply to iPSCs, accounting for their spectrumof imprinting alterations.
Such differences in imprinting regulation should be taken into consideration for the use of iPSCs in disease modeling.
Introduction
Genomic imprinting is a mammalian epigenetic phenomenon
that causes a subset of genes to be monoallelically expressed
according to their parental origin. These genes typically cluster
together in 20–25 chromosomal regions in the mammalian
genome containing genes exclusively expressed from the
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maternally or the paternally inherited alleles. Regulation of
imprinting at these clusters relies on a cis-acting element known
as imprinting center (IC), which exhibits parental-specific differ-
ences in CpGmethylation inherited from the germline (reviewed
in 1,2). Apart from the IC, other differentially methylated regions
(DMRs) are also important for regulating imprinted expression
of certain genes in the cluster. These DMRs, known as secondary
DMRs, acquire differential methylation after the implantation
stages of development and their methylation status and action
is dependent hierarchically from the IC. That is, if the IC shows
aberrant loss or gain of methylation, secondary DMRs show
inappropriate loss or gain of methylation in the same parental
allele (1,3). The molecular mechanisms underlying hierarchical
regulation between germline and secondary DMRs remain to be
deciphered.
(Epi)genetic alterations at these imprinted regions cause
congenital syndromes known as imprinting disorders. There
are at least 12 of these syndromes that typically affect growth,
development, metabolism and brain function (4). The human
chr15q11-q13 (Fig. 1A) harbors an imprinted cluster of genes
associated with two classical imprinted neurodevelopmental
disorders, Angelman Syndrome (AS) (OMIM#105830) and Prader–
Willi Syndrome (PWS) (OMIM#176270). Patients with AS are
characterized by severe intellectual disability, developmental
delay, seizure, ataxia and happy demeanor (5). AS is caused by
the loss of the maternally inherited copy of the E3 ubiquitin
ligase UBE3A gene, which is expressed from both alleles in
the majority of tissues, but exclusively expressed from the
maternal allele in neurons (6,7). Patients with PWS suffer from
neonatal hypotonia and poor feeding initially, but children
eventually develop hyperphagia-induced obesity and typically
exhibit obsessive-compulsive behaviors. PWS is believed to
be caused by the loss of two or more paternally expressed
imprinted genes within the segment from MKRN3 to the small
nucleolar RNA (snoRNA) genes (8) (Fig. 1A). More recently, other
diseases have been linked to this imprinted region, such as
15q11-q13 duplication syndrome (OMIM#608636), characterized
by intellectual disability and autistic spectrum disorder (9),
Schaaf-Yang syndrome (caused by paternally inherited MAGEL2
mutations) (OMIM#615547), which is phenotypically related to
PWS and autism (10) and central precocious puberty 2 (caused
by paternally inherited MKRN3 mutations) (OMIM#615346) (11).
Imprinting regulation within the chr15q11-q13 region is con-
trolled by a bipartite IC composed of two elements: AS imprint-
ing center (AS-IC) and PWS imprinting center (PWS-IC; reviewed
in 6). AS-IC is an 880 bp region located 35 kb upstream of
the binary SNURF-SNRPN promoter. AS-IC is postulated to drive
transcription from upstream exons of the SNURF-SNRPN gene in
the maternal germline to establish a CpG methylation imprint
at the PWS-IC (12). PWS-IC is situated on the promoter and exon
1 of the SNURF-SNRPN gene (Fig. 1A). This region is methylated
on the maternal allele and unmethylated on the paternal allele.
The unmethylated paternal allele drives the expression of a
polycistronic transcript which includes the SNURF-SNRPN pair,
the non-coding transcript IPW and several snoRNAs on the distal
part of the cluster (Fig. 1A). In neurons, transcription contin-
ues further to produce the UBE3A anti-sense (UBE3A-ATS) long
non-coding RNA which is believed to silence the paternal UBE3A
allele (6,13). The proximal part of the cluster is composed by
several intronless genes exclusively expressed from the paternal
chromosome, including the MKRN3 and NDN genes. These two
genes have differentiallymethylated CpG islands at their respec-
tive promoters which, like the PWS-IC, are unmethylated on the
paternally inherited allele and methylated on the silent mater-
nal allele (14,15). Mutations or epimutations (changes in DNA
methylation pattern) of the PWS-IC alter the epigenetic profile,
including of the NDN and MKRN3 DMRs, and allelic expression
of the whole region (16,17), confirming PWS-IC as the master
regulator of imprinting of the PWS/AS region in somatic tissues.
An exception to this was observed in two PWS patients with
an unusual milder phenotype. These PWS patients presenting
maternal uniparental disomy with methylated PWS-IC on both
alleles have unexpected expression of a few imprinted genes
commonly silenced in PWS, including MKRN3. This suggest that
some relaxation on imprinting regulation governed by PWS-IC
can occur at this 6 Mb imprinted cluster, at least, in a disease
context (18) suggesting that PWS/AS locus can be susceptible to
independent epigenetic changes throughout the cluster.
In recent years, the emergence of the induced Pluripotent
Stem Cell (iPSC) technology gave the unprecedented possibility
to reprogrampatient-derived somatic cells into stem-like cells to
study a wide variety of human disorders (19). In a disease con-
text, patient-derived iPSCs can be differentiated into the affected
cell-type or tissue to function as a disease cellular model. iPSCs
can and have been also used for modeling imprinted diseases
(20). However, an important issue is whether ICs conserve their
DMR status during the global epigenetic rewiring accompanying
somatic reprogramming into iPSCs. Indeed, several reports have
clearly pointed to the existence ofmultiple, but variable, imprint-
ing defects in iPSCs (21–24), although themolecularmechanisms
causing these defects remain largely unknown. For instance,
whether ICs remain as the elements that hierarchically control
the epigenome of an entire imprinted cluster in iPSCs, as they
normally do in somatic cells, has not been addressed.
iPSCs have been derived from patients with imprinted
syndromes associated with the 15q11-q13 region (25–29) to
start unravelling molecular and cellular features associated
with these syndromes (30,31). Interestingly, PWS-IC methylation
status is reported to be generally stable in these AS and PWS-
derived iPSCs (25,27,30). However, other studies reported a
tendency for a certain degree of hypomethylation of the PWS-IC
in normal or PWS-derived cells (23,32), though the functional
consequences of PWS-IC hypomethylation, if any, have not
been addressed. Interestingly, genome-wide studies suggest that
the promoter of MKRN3 has a tendency to gain methylation in
normal iPSCs (22,23). Whether this is dependent or independent
of the PWS-IC methylation status remains unknown.
By reprogramming skin fibroblasts with the Yamanaka fac-
tors from healthy and AS individuals, we generated two groups
of isogenic iPSC lines (five lines from the healthy control indi-
vidual and five lines from an AS patient). Interestingly, we could
detect a maternal to paternal epigenotype switch at the PWS-
IC in one of our control iPSCs. Such alteration has widespread
consequences for the imprinting regulation of the locus. Inter-
estingly, we also found that the PWS-IC loses its ability to influ-
ence epigenetic status of theMKRN3DMR,not only in our derived
lines, but also in reported control and AS iPSCs. Our results
indicate an alteration of the hierarchical influence of regulatory
regions within imprinted loci in iPSCs which should be taken
into consideration for disease modeling.
Results
Correct imprinting status of the chr15q11-q13 in skin
fibroblasts derived from a healthy donor and a patient
with AS
Fibroblasts from a 30-year-old female patient with AS and an
age- and sex-matched healthy individual were derived from a
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Figure 1. Stable imprinting of the chr15q11-q13 region in Ctrl and AS FIBs. (A) Scheme of the predictive epigenetic and transcriptional profile of the human chr15q11-q13
region in Ctrl and AS FIBs. Green rectangles, non-imprinted genes (* indicates that ATP10A imprinting status is uncertain); blue rectangles, imprinted genes expressed
from the paternal allele; red rectangles, imprinted genes expressed from the maternal allele; gray rectangles, non-expressed imprinted genes; the rectangle with blue
and gray stripes represents neuronal-specific imprinted expression of the paternal UBE3A gene; AS-IC is highlighted in yellow; white lollipops, unmethylated DNA;
black lollipops, fully methylated DNA; half black lollipops, partially methylated DNA; Pat, paternal allele; Mat,maternal allele; BP1 to 5, breaking points 1 to 5. (B) PWS-IC
COBRA for Ctrl and AS FIBs. White circle, unmethylated band; half black circle, partially methylated band; black circle, fully methylated band. (C) Bisulfite sequencing
analysis for PWS-IC in Ctrl and AS FIBs. Each line represents the methylation profile of an independent PCR amplicon as determined by Sanger sequencing and BiQ
Analyser. White dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition sites used for PWS-IC COBRA are indicated; the numbers in brackets
represent the number of times the same amplicon was sequenced; estimated number of bacterial clones obtained in the Luria-Bertani (LB) agar plates is indicated. (D)
RT-qPCR analysis for SNRPN and UBE3A in Ctrl and AS FIBs. Relative expression has been normalized to the GAPDH housekeeping gene; data are the mean ± standard
error of the mean (SEM) of at least three independent experiments; significant differences between Ctrl and AS FIBs are indicated with an asterisk as P-value < 0.05,
unpaired Student’s t-test. (E) Allelic-specific SNRPN genomic and expression analysis in Ctrl FIBs assayed by Sanger sequencing. Yellow stripe indicates the rs705 SNP.
(F) UBE3A nascent-transcript RNA FISH in Ctrl and AS FIBs. Percentage of biallelic/monoallelic UBE3A FISH signals was calculated by counting a minimum of 64 cells
per sample.
punch skin biopsy and established in culture using standard
conditions (33). The patient with AS harbors a 4.8 Mb deletion of
the maternal 15q11-q13 locus, between breaking points 2 and 3
(from MKRN3 to HERC2 genes, including UBE3A). Megadeletions,
as this one, are the most common defects in AS, accounting for
70–80% of the cases (5) (Fig. 1A). To understand whether imprint-
ing status was correctly maintained in the cultured fibroblasts,
we analyzed the methylation status of the PWS-IC, the master
regulator of imprinting at the 15q11-q13 region by combined
bisulfite restriction analysis (COBRA) and bisulfite sequencing.
For COBRA, genomic DNA was initially treated with sodium
bisulfite to distinguish methylated from unmethylated CpGs.
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After amplification using a nested Polymerase Chain Reaction
(PCR) approach (33), a restriction enzyme was used to recognize
three methylation-dependent retained sites within the PCR
product (Supplementary Material, Table S1). AS fibroblasts
(AS FIBs), as expected, only have an unmethylated allele, which
was not cleaved by the restriction enzyme and corresponds
to the single paternal allele. In contrast, in control fibroblasts
(Ctrl FIBs) from the healthy donor, we could identify several
bands that correspond to both fully methylated (three bands of
similar size: 93, 110 and 115 bp), partially methylated (∼230
bp) and unmethylated (340 bp) alleles (Fig. 1B). Presumably,
the unmethylated band corresponds to the paternal allele,
while both fully and partially methylated bands correspond to
the maternal allele. These results were confirmed by bisulfite
sequencing, a technique whereby post-PCR single amplicons
are ligated, cloned and then sequenced to retrieve methylation
information of several CpG dinucleotides within the PCR
product. After ligation and cloning, there was a reduced number
of bacteria colonies for AS FIBs compared to Ctrl FIBs in replicate
experiments (AS FIBs < 20 and Ctrl FIBs > 200) (Fig. 1C). Despite
the clear cloning bias towardmethylated amplicons in this assay,
both unmethylated and methylated amplicons were observed
for Ctrl FIBs, while only unmethylated amplicons were observed
for AS FIBs (Fig. 1C). All in all, these results suggest that cultured
fibroblasts maintained the expected methylation status of PWS-
IC.
We then explored the expression and imprinting profile of the
paternally expressed SNRPN imprinted gene and the biallelically
expressed UBE3A gene, both of which are absent from the
maternal chromosome in AS FIBs (Fig. 1A). The SNRPN levels
were found to be equivalent between AS and Ctrl FIBs, while the
levels of UBE3A were found to be at least 2-fold decreased in AS
FIBs compared to Ctrl FIBs (Fig. 1D), suggesting that absence of
the expressing maternal copy results in around 50% decrease
in UBE3A expression. To address the imprinted expression
of SNRPN in Ctrl FIBs, we were fortunate to find the single
nucleotide polymorphism (SNP) rs705 in the 5′UTR of SNRPN
gene, allowing for allelic-specific expression analysis. While
both nucleotides (T/C) could be detected at the deoxyribonucleic
acid (DNA) level, only one of them (T) was detected at the
complementary DNA (cDNA) level indicating that SNRPN is,
as expected, monoallelically expressed (Fig. 1E). In contrast to
SNRPN, no SNP could be found in UBE3A exons (data not shown).
Therefore, we developed a StellarisTM UBE3A RNA Flourescent In
Situ Hybridyzation (RNA FISH) (35) using a probe detecting the
UBE3A nascent transcript. As expected most of Ctrl FIBs (70.3%)
have two fluorescent dots for UBE3A, while the vast majority
of AS FIBs has only one dot (83.1%) (Fig. 1F). These results
suggest that the two UBE3A alleles in Ctrl FIBs and the single
paternal copy of UBE3A in AS FIBs are expressed as expected,
since UBE3A imprinting is only reported in neurons (6,7). In
conclusion, a profile consistent with the expected epigenetic
and transcriptional landscape was maintained in cultured Ctrl
and AS FIBs.
Creation of iPSCs from a healthy donor and a patient
with AS
To study the stability of imprinting at the chr15q11-q13 region
in normal and in disease context, we reprogrammed both Ctrl
and AS FIBs to obtain distinct iPSC lines. The creation of two
set of isogenic lines, one from Ctrl FIBs and other from AS
FIBs, greatly limits the influence of genetic factors on putative
imprinting defects. Yamanaka reprogramming was performed
using a lentiviral vector expressing the OCT4, SOX2, KLF4, C-MYC
(OSKM) cassette plus a fluorescent tractable marker (dTomato)
using a previously established protocol (36). At the beginning
of reprogramming, activation of the OSKM cassette could be
followed with the dTomato fluorescent trackable marker (data
not shown), which became silenced 3 weeks later as previously
shown (36). Five independent iPSC clones from both Ctrl and
AS FIBs were isolated. They were initially cultured in feeder-
dependent conditions, but adapted to feeder-free mTeSR1
conditions around passage 4, displaying embryonic stem
cell (ESC)-like morphology and self-renewal capacities (data
not shown). Karyotyping was done for the majority of the
iPSC clones and found to be normal with the exception for
Ctrl C and AS B iPSCs, which displayed a few chromosomal
aberrations (Supplementary Material, Fig. S1A). iPSCs were
then characterized for expression of stem cell factors by
both immunofluorescence (IF) and Reverse Transcriptase-
quantitative Polymerase Chain Reaction (RT-qPCR) analysis with
more detailed analyses performed for the Ctrl E, Ctrl B and AS
E iPSC lines. As expected, NANOG and SOX2 markers strongly
stained all iPSC lines checked by IF (Fig. 2A). Likewise, stem-cell
markers (OCT4, SOX2, NANOG and REX1), but not the fibroblast
marker COL1A1, were expressed as assessed by RT-qPCR in the
same cells (Fig. 2B). These results were confirmed by RT-qPCR
analysis for the full panel of Ctrl and AS iPSCs and compared to
the published AG1-0 iPSC line (Supplementary Material, Fig. S1B)
which harbors a similar megadeletion to our AS iPSC lines (24).
These results confirmed that we successfully reprogrammed
healthy and AS FIBs into five independent stem-like clones
of cells.
Reprogramming-induced methylation changes in
PWS-IC cause loss of imprinting at the chr15q11-q13
To assess the stability of imprinting status of the chr15q11-
q13 locus in normal and in disease context, we first analyzed
whether themethylation status of the PWS-IC inherited from the
initial Ctrl and AS FIBs was maintained upon reprogramming.
For that, we performed COBRA for PWS-IC in the generated
iPSC lines. All AS iPSC lines presented only the unmethylated
paternal allele, preserving themethylation status inherited from
AS FIBs (Fig. 3A and Supplementary Material, Fig. S2A). Four of
the Ctrl iPSC lines (Ctrl A, C, D & E) also maintained the inherited
methylation pattern fromCtrl FIBs,presenting both anunmethy-
lated band, presumably corresponding to the paternal allele, and
partially and fully methylated bands, presumably correspond-
ing to the maternal allele (Fig. 3A and Supplementary Material,
Fig. S2A). These results agree with previous studies demonstrat-
ing thatmethylation pattern at PWS-IC remains stable (25,27,30).
Interestingly, in contrast to the other Ctrl iPSC lines, Ctrl B
iPSCs exhibit only the unmethylated band (Fig. 3A). Since the
nearby rs705 SNP of the SNRPN gene was still present in Ctrl
B iPSC line (Fig. 3C), a deletion of the PWS-IC was unlikely to
explain this result. Instead, this data suggests a maternal-to-
paternal epigenotype switch of the PWS-IC. Bisulfite sequencing
confirmed the COBRA results: Ctrl B iPSC, like AS A iPSC, only
had unmethylated amplicons,while Ctrl A iPSC had bothmethy-
lated and unmethylated alleles (overrepresentation of methy-
lated amplicons due to cloning bias as also found for Ctrl FIBs)
(Fig. 3B). To rule out that the putative loss of methylation on
the maternal PWS-IC was not due to a global methylation loss,
we decided to interrogate the methylation status of the IC from
another imprinted region, the InterGenic-DMR (IG-DMR) of the
DLK1-MEG3 domain by COBRA. IG-DMR is known to be frequently
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Figure 2. Stem-cell markers are expressed in Ctrl and AS iPSCs. (A) IF for SOX2 and NANOG (in red) in Ctrl B, Ctrl E and AS E iPSCs. Nuclei are marked with DAPI in
blue; bar scale = 100 μm. (B) RT-qPCR analyses for the fibroblast marker (COL1A1) and the stem cell markers (OCT4, SOX2, NANOG and REX1) in Ctrl FIB, AS FIB, Ctrl B,
Ctrl E and AS E iPSCs. Relative expression has been normalized to the GAPDH housekeeping gene; data are the mean ± SEM of at least two independent experiments;
COL1A1 RT-qPCR values were normalized to 1 for the Ctrl FIBs sample, while OCT4, SOX2, NANOG and REX1 RT-qPCR values were normalized to 1 for the Ctrl E iPSC
sample; significant differences toward the Ctrl FIBs sample are indicated with an asterisk as P-value < 0.05, unpaired Student’s t-test.
hypermethylated in iPSCs (22,23).We observed that in Ctrl B iPSC
line, IG-DMR has the expected methylation pattern with both
the presence of the unmethylated and methylated bands, ruling
out an overall methylation defect in this line. Interestingly, a
bias toward the methylation band (AS A, B, C & D), or complete
reversal to a single methylated band was observed for the IG-
DMR (Ctrl C & D) (Fig. 3A and Supplementary Material, Fig. S3A),
as previously found in iPSCs (22,23).
The putative imprinting defect in Ctrl B iPSCs highlights
the existence of methylation alterations at the level of PWS-IC
in iPSCs. A tendency for decreased methylation at PWS-IC in
certain iPSCs has been previously suggested (23,32), however the
functional consequences of such an alteration has never been
explored. Taking advantage of the known exonic SNP (rs705) in
the SNRPN gene, we asked whether loss of methylation at the
maternal PWS-IC in Ctrl B iPSCs resulted in loss of imprinting,
i.e. biallelic expression of the SNRPN gene. Indeed, allelic-
specific Reverse Transcriptase-Polymerase Chain Reaction
(RT-PCR) showed that SNRPN, which is paternally expressed in
the normal Ctrl A, Ctrl D, AS D and AS E iPSCs, becomes bialleli-
cally expressed in Ctrl B iPSCs (Fig. 3C; Supplementary Material,
Fig. S3B). Moreover, nascent transcript RNA FISH for the
SNORD116 snoRNA cluster showed a switch from themonoallelic
to the biallelic state in Ctrl B iPSCs, but not in normal Ctrl E or
AS E iPSCs (Fig. 3D). As expected expression of the UBE3A gene
which is not imprinted in iPSCs remains biallelic in the Ctrl B and
Ctrl E lines, and expressed from the sole paternal allele in the
AS E line (Fig. 3D). Importantly, the reported imprinting status in
Ctrl B or in any other iPSCs was not altered in the range of cell
passages we studied (passages 7–19). In conclusion, we found
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Figure 3. Loss of methylation at the maternal PWS-IC in Ctrl B iPSC results in loss of imprinting of genes at the chr15q11-q13. (A) PWS-IC and IG-DMR COBRA for
Ctrl and AS FIBs and several iPSCs (Ctrl A, Ctrl B, Ctrl E; AS A and AS E). White circle, unmethylated band; half black circle, partially methylated band; black circle,
fully methylated band. (B) Bisulfite sequencing analysis for PWS-IC in Ctrl A, Ctrl B and AS A iPSCs. Each line represents the methylation profile of an independent
PCR amplicon as determined by Sanger sequencing and BiQ Analyser; white dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition sites used
for PWS-IC COBRA are indicated; the numbers in brackets represent the number of times the same amplicon was sequenced; estimated number of bacterial clones
obtained in the LB agar plate is indicated. (C) Allelic-specific SNRPN expression analysis assayed by Sanger sequencing for the Ctrl A, Ctrl B and AS E iPSCs. Yellow
stripe indicates the rs705 SNP. (D) Nascent-transcript RNA FISH for UBE3A and SNORD116 in Ctrl E, Ctrl B and AS E iPSCs. Percentage of biallelic/monoallelic UBE3A and
SNORD116 FISH signals was calculated by counting a minimum of 100 cells per sample.
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Figure 4. MKRN3 DMR, but not NDN DMR, is hypermethylated in Ctrl iPSCs. (A) NDN COBRA for Ctrl FIBs, Ctrl B and Ctrl E iPSCs. White circle, unmethylated band;
black circle,methylated band. (B) Allelic-specific NDN expression analysis assayed by Sanger sequencing for Ctrl FIBs, Ctrl B and Ctrl E iPSCs. Yellow stripe indicates the
rs2192206 SNP. (C) MKRN3 COBRA for Ctrl FIBs and all the isogenic Ctrl iPSCs. White circle, unmethylated band; black circle, methylated band. (D) Bisulfite sequencing
analysis for MKRN3 DMR in Ctrl FIBs, Ctrl B and Ctrl E iPSCs. Each line represents the methylation profile of an independent PCR amplicon as determined by Sanger
sequencing and BiQ Analyser; white dots, unmethylated CpGs; black dots, methylated CpGs; Bsh1236I recognition site used for MKRN3 DMR COBRA is indicated; the
numbers in brackets represent the number of times the same ampliconwas sequenced; estimated number of bacterial clones obtained in the LB agar plates is indicated.
that one of the generated iPSCs lost methylation of the maternal
PWS-IC and, as a consequence, displayed biallelic expression of
the polycistronic RNA initiated from the promoter region where
PWS-IC is situated.
PWS-IC fails to fully control the epigenetic landscape
across the chr15q11-q13 in iPSCs
Imprinting dysregulation is a known side-effect of current iPSC
reprogramming protocols,withmany ICs switching their methy-
lation patterns and causing loss of imprinting of the neighbour-
ing genes (21–24). However, whether ICs remain the imprinting
master regulator within a cluster in iPSCs has never been func-
tionally dissected. Taking advantage of our isogenic Ctrl iPSC
lineswith normal (Ctrl A,C,D&E) and abnormal (Ctrl B)methyla-
tion patterns at PWS-IC (Fig. 3A and B; Supplementary Material,
Fig. S3A), we decided to explore the impact of these changes on
the methylation profile of the two most-studied somatic DMRs
(NDN and MKRN3 DMRs) at the proximal part of the chr15q11-
q13 region by COBRA. For the NDN DMR, we verified that the
normal Ctrl E iPSC line exhibits the same band pattern as the
Ctrl FIBs sample, with both a strong unmethylated and a weak
methylated band (Fig. 4A). In contrast, Ctrl B iPSCs only have
an unmethylated band (Fig. 4A), suggesting that the maternal
allele fully lost its normal methylation. Through the presence
of an exonic SNP at the NDN gene (rs2192206), we verified that
NDN became biallelically expressed in Ctrl B iPSCs, remaining
monoallelically expressed in Ctrl E iPSCs, as in the original
Ctrl FIBs sample (Fig. 4B). These results suggest a maternal-to-
paternal epigenotype switch on the NDN DMR, similar to the
changes at the level of the PWS-IC in Ctrl B iPSCs. Therefore,
NDN DMR seems to be hierarchically dependent on the PWS-IC
in iPSCs.
We then investigated the methylation pattern at the MKRN3
DMR.While both a methylated and an unmethylated band were
observed for Ctrl FIBs, we verified that, surprisingly, all the Ctrl
iPSCs displayed a tendency for hypermethylation at the MKRN3
DMR by COBRA (Fig. 4C). This occurred independently of the
methylation pattern at the PWS-IC, since the Ctrl B iPSC line
also exhibits the same hypermethylation pattern as the other
Ctrl iPSCs. This result was confirmed by bisulfite sequencing:
while unmethylated andmethylated amplicons were sequenced
in the Ctrl FIBs sample, both Ctrl B and Ctrl E iPSCs showed
a clear accumulation of hypermethylated amplicons (Fig. 4D).
Moreover, all the AS iPSCs lines also showed a tendency for
MKRN3 to become hypermethylated (Supplementary Material,
Fig. S3A). All together, these results suggest that MKRN3 DMR
no longer responds to the PWS-IC methylation status and tends
to become hypermethylated during iPSC reprogramming. This
finding showed that iPSCs, in contrast to the donor somatic cells,
exhibit a loss of hierarchical control of imprinting by PWS-IC in
the chr15q11-q13 region. The reasons why some regions, such
as the MKRN3 DMR, but not others (e.g. NDN DMR) gain ectopic
methylation during iPSC derivation need to be further explored.
An interesting perspective is that the lack of the neuronal-
specific MKRN3 expression, but not of NDN (or MAGEL2) dur-
ing reprogramming (Supplementary Material, Fig. S3B), might
explain the aberrant gain of methylation on the paternal allele.
MKRN3 DMR hypermethylation, independent of PWS-IC
regulation, is a frequent event in iPSCs
To corroborate the results obtained with our iPSC lines, we
examined themethylation profile of both the PWS-IC andMKRN3
DMR in five independent iPSC lines previously generated using
different reprogrammingmethods (Fig. 5A) (25,37–39) (Silva et al.,
in preparation). This includes the AG1-0 line derived from an AS
patient with a similar megadeletion to our AS iPSCs (25). Using
COBRA,we found the normalmethylation pattern at the PWS-IC,
with both unmethylated (corresponding to the paternal allele)
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and partially and fully methylated bands (corresponding to the
maternal allele) in three out of the five previously generated iPSC
lines (Fig. 5B). As expected, the AG1-0 AS iPSC line only showed
the sole unmethylated paternal allele, as previously found in
all our derived AS iPSCs (Fig. 3A and Supplementary Material,
Fig. S3A). Interestingly, the iUC-DAND5_455/10 (iUC-DAND5 for
short) iPSC line, with no genetic defects in chr15q11-q13, seems
to have lostmaternalmethylation at the PWS-IC (Fig. 5B), similar
to the Ctrl B IPSC line (Fig. 3A). This highlights for the fact that
PWS-IC hypomethylation defects in iPSCs are more recurrent
than initially appreciated.
We then verified the methylation pattern of the MKRN3
DMR in these iPSCs. In four out of the five iPSCs, including
AG1-0, a clear tendency for hypermethylation at the level of
the MKRN3 DMR is observed. This demonstrated that MKRN3
DMR hypermethylation is indeed frequent in iPSCs regardless
of the reprogramming procedure. As described for the Ctrl B
iPSC line, hypomethylation of the maternal PWS-IC in the iUC-
DAND5 iPSC did not impact the gain of methylation at the
MKRN3 DMR (Fig. 5B). Only the iPSC6.2 line was found to have
both the unmethylated and methylated alleles (with some bias
toward the unmethylated allele). Overall, by using established
iPSC lines, we confirmed the results from our isogenic system.
Indeed, we confirmed that MKRN3 DMR hypermethylation
and loss of hierarchical control of the IC of the Prader–
Willi/Angelman imprinted cluster are frequent events occurring
upon reprogramming into iPSCs (summarized in Fig. 5C).
Discussion
Imprinting defects are known to accumulate in iPSCs (21–24);
however, the frequency and causes underlying these defects
remain to be understood. In particular, it is not known whether
imprinting dysregulation is driven only by epigenetic changes
in the ICs or whether epigenetic alterations in other regions
could also account for imprinting errors accumulated during
reprogramming. In this study, we evaluated the impact of
Yamanaka reprogramming in the imprinting regulation of
the PWS/AS region on chr15q11-q13. We found that PWS-IC,
the master regulator of chr15q11-q13 imprinting, is mostly
resistant to changes in its parental-inherited methylation
profile. However, loss of maternal methylation was found in
one derived and one published iPSC lines. Loss of maternal
methylation at the PWS-IC caused loss of imprinting of many
genes within the cluster. Interestingly, PWS-IC lost the ability
to control differential methylation at the MKRN3 DMR, which
showed a propensity to gain aberrant methylation in iPSCs.
These results highlight, for the first time, a change in the
hierarchy of imprinting regulation within imprinted domains
in iPSCs.
Skin fibroblasts in culture seem to maintain their methy-
lation profiles intact across the chr15q11-q13 in both Ctrl and
AS FIBs (Fig. 1). We cannot completely rule out for undetectable
imprinting defects in a minority of fibroblasts, since we have
not performed single-cell analysis (except for UBE3A nascent-
transcript RNA FISH). In any case, these results are in agree-
ment with previous publications, suggesting stable imprinting
in cultured skin fibroblasts (25,27). To generate isogenic Ctrl and
AS iPSC lines, we used a standardized lentiviral approach (36)
for somatic reprogramming, which has been previously used
to generate AS iPSCs carrying UBE3A mutations (27). We con-
firmed that our five isogenic AS and five isogenic Ctrl iPSCs
have ESC-like morphology, self-renewal capacity, express stem
cell markers and mostly have a normal karyotype (Fig. 2 and
Supplementary Material, Fig. S2). The use of independent but
genetically identical iPSCs lines provided a good starting point to
study the epigenetic stability of the PWS/AS imprinting cluster
in both healthy background and disease context.
We began by addressing the status of PWS-IC in the different
iPSCs. We detected that the karyotypically normal Ctrl B iPSC
line lost methylation on the maternal allele, while the pater-
nal allele remained unmethylated in both Ctrl and AS iPSCs
(Fig. 3A and Supplementary Material, Fig. S2A). Loss of methy-
lation at the PWS-IC was also seen in the IUC-DAND5 iPSC
line (Fig. 5B), suggesting that the maternal PWS-IC has some
propensity to lose methylation during reprogramming, while
the paternal PWS-IC seems to remain unmethylated and inert
to methylation aberrations. This data contrasts with previous
studies reporting a stable parental-inherited methylation pat-
tern in healthy, AS and PWS iPSCs for PWS-IC (25,27,30). How-
ever, our results corroborate other findings reporting partial
hypomethylation of the PWS-IC in normal or PWS-derived iPSCs
(23,32). A direct implication of this is that AS iPSCs derived from
patients with megabase deletions (65–70% of patients with AS)
(5) with only the unmethylated paternal PWS-IC are less likely to
accumulate imprinting errors at this element and, thus, might
provide a good cellular system to model AS. In contrast, PWS
iPSCs derived from patients with megabase deletions (70–80% of
patients with PWS) (8) containing only the methylated maternal
PWS-IC will be prone to hypomethylation defects with possible
consequences in imprinting regulation of the locus. In any case,
independently of acquiring reprogramming-induced imprinting
defects or not, the methylation profile of iPSCs remains there-
after stable through cell passage and cell differentiation (data
not shown) (23,30). Nevertheless, our results suggest that recur-
rent screening for methylation errors at the level of PWS-IC
should be advised in iPSCs used to study diseases affecting the
chr15q11-q13 region.
Given the observedmaternal-to-paternal epigenotype switch
in the PWS-IC in Ctrl B iPSCs (Fig. 3A), we explored the extent to
which imprinting of the chr15q11-q13 region was affected. We
observed that genes within the polycistronic transcript initiated
at the PWS-IC, such as SNRPN and SNORD116 genes, became
biallelically expressed (Fig. 3C and D). Loss of imprinting was
also seen for the NDN gene, which lies on the proximal part
of the domain. This was accompanied by the loss of maternal
methylation at the NDN DMR (Fig. 4A and B). Overall, we report,
for the first time in iPSCs, that loss of maternal PWS-IC has
widespread effects on imprinting regulation of the chr15q11-q13
region. Interestingly, around 3% of AS cases arise from similar
imprinting defects resulting in loss of maternal methylation
of the PWS-IC (5). In principle, such a reprogramming-induced
imprinting defect can be used tomodel the cases of AS caused by
loss of maternal methylation at the PWS-IC, a distinct molecular
mechanism causing the disease from the megabase deletions or
mutations in the UBE3A gene.
A surprising finding from our study was the fact that in
contrast to the NDN DMR, the MKRN3 DMR does not respond to
alterations in the PWS-IC methylation status (Fig. 5B). Moreover,
a clear tendency to become hypermethylated was seen, not only
in all our healthy and AS-derived iPSCs, but also on previously
established iPSCs, with only one exception (the iPSC6.2 line)
(Fig. 4C and D; Fig. 5B; Supplementary Material, Fig. S3A). These
results confirm unexplored reports onMKRN3DMR hypermethy-
lation in iPSCs previously gathered from genome-wide studies
(22,23). To our knowledge, MKRN3 DMR hypermethylation has
never been observed in any other tissues or cell types. Further-
more, our findings clearly point toward a loss of the hierarchical
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Figure 5. Hypermethylation of theMKRN3 DMR is a frequent event in iPSCs and escapes control by the PWS-IC. (A) Summary table of the features of the five established
iPSC lines used. (B) PWS-IC and MKRN3 DMR COBRA in the five iPSC lines (and also in Ctrl FIBs for MKRN3 DMR). White circle, unmethylated band; half black circle,
partially methylated band; black circle, fully methylated band. (C) Scheme of the expected and the observed epigenetic and transcriptional profile of the human
chr15q11-q13 region in Ctrl and AS iPSC lines. Blue rectangles, imprinted genes expressed from the paternal allele; red rectangles, imprinted genes expressed from
the maternal allele; gray rectangles, silenced imprinted genes; white lollipops, unmethylated DNA; black lollipops, methylated DNA; Pat, paternal allele; Mat, maternal
allele; green arrowheads highlight the epigenetic errors found; iPSCs lines in black correspond to the lines generated in this study; iPSCs in red correspond to the
previously published IPSC lines.
regulation of imprinting at the chr15q11-q13, a situation only
reported once before in two PWSpatientswithmilder phenotype
(18). Indeed, PWS-IC no longer exerts its master imprinting regu-
lator role as it normally does in somatic cells (16,17). The reasons
why changes in the hierarchy of imprinting regulation for the
chr 15q11-q13 occur in iPSCs remains to be understood. It is also
unclear why MKRN3 DMR gains methylation, while the same
is not observed for NDN DMR. A possible explanation centers
on the fact that MKRN3, in contrast to NDN, is silent from both
alleles and presumably becomes prone to acquire methylation
on the unmethylated, albeit silenced, paternal allele. This likely
occurs during the reprogramming process since theMKRN3DMR
remains differentially methylated in fibroblasts, despite the fact
that MKRN3 gene is also not expressed in this cell type. Further
studies will be necessary to understand the role of the initial cell
source (the only iPSC line with noMKRN3 hypermethylation was
derived from CD34+ progenitors) (Fig. 5A and B) or of reprogram-
ming methods on the aberrant hypermethylation of the MKRN3
DMR in many iPSCs.
By exploring the mechanisms of imprinting regulation at the
PWS/AS imprinted cluster in depth, we documented several
anomalies on methylation pattern and unravelled changes
in the hierarchy of imprinting regulation in iPSCs. Whether
imprinting defects at other clusters (e.g. DLK1-DIO3 cluster is
also affected in some of our iPSC lines) might also lead to
changes in the imprinting regulatory principles documented
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for normal somatic cells will need to be explored in the
future. In any case, our study clearly suggests that imprinting
defects in iPSCs might also occur in somatic or secondary
DMRs, regardless of epigenetic alterations at the respective
IC. This increases the current spectrum of imprinting defects
associated to this cell type likely to cause loss of imprinting
for certain gene(s) within an imprinted cluster. This also
highlights for the need to screen for epigenetic defects in
all imprinting regulatory regions within a cluster and not
only at the IC. Interestingly, by presenting such flexibility of
imprinting regulation, iPSCsmight become a good cellularmodel
to study the relationships between regulatory elements within
an imprinted domain to achieve long-range transcriptional
regulation. Finally, the impact these hierarchical changes of
imprinting regulation will have on iPSC differentiation toward
committed lineages will certainly be an important issue to




Fibroblast punch biopsies from both the patient with AS and
the age- and sex-matched individual were collected in Hospital
de Santa Maria (Centro Hospitalar Lisboa Norte) in accordance
with European and National ethical regulation and approved
by the Ethical Committee of Instituto de Medicina Molecular
João Lobo Antunes (iMM) and Hospital de Santa Maria. For the
Ctrl individual, written informed consent was obtained. For
the patient with AS, written informed consent was obtained
from the patient’s legal guardians. Isolation and maintenance
of fibroblasts were performed according to a standardized
protocol (33). For AS FIBs, a 4.8 Mb deletion of the 15q11-
q13 between breaking points 2 and 3 (from MKRN3 to HERC2
genes) was confirmed using a chromosomal array CGH 180K
(performed by Serviço de Genética, Departamento de Patolo-
gia, Faculdade de Medicina, Universidade do Porto). Human
fibroblasts were maintained in DMEM supplemented with
10% fetal bovine serum, 1 mm L-Glutamine, and 100 units/ml
penicillin, 100 μg/ml streptomycin using products from Life
Technologies in a humid incubator at 37◦C with 5% (vol/vol)
CO2.
Yamanaka reprogramming
iPSC reprogramming of AS and Ctrl FIBs was performed using a
previously published protocol (36). Briefly, pluripotency of adult
humanAS and Ctrl FIBswas inducedwith a polycistronic lentivi-
ral vector encoding for the reprogramming OSKM cassette and a
red fluorescent protein (dTomato) under the spleen focus-forming
virus promoter (36). Transduced fibroblasts were harvested via
trypsinization and transferred onto mouse embryonic fibrob-
lasts (MEFs) 3 days after transduction and thereafter cultured
in human embryonic stem cell (hES) medium composed by
DMEM F-12 (Gibco, Invitrogen), 15% Knock-out serum replace-
ment, 1mm L-glutamine (Gibco, Invitrogen), 0.1mmnonessential
amino acids (Sigma-Aldrich), 100 μM β-mercaptoethanol (Sigma-
Aldrich), 100 units/ml penicillin, 100 μg/ml streptomycin (Gibco,
Invitrogen) and 10 ng/ml of basic Fibroblast Growth Factor (bFGF;
Peprotech). From day 21 of reprogramming, the first ESC-like
colonies appear and single colonies were picked based on mor-
phology and further expanded on a MEF feeder layer. A total of
five iPSC lines derived from AS and Ctrl FIBs each were obtained.
iPSC culture
iPSCs were initially expanded in hES medium under MEF feeder-
dependent conditions. When colonies reached 50–75% conflu-
ency, cells were passed with a splitting ratio from 1:2 to 1:4 using
0.5 mm EthyleneDiamineTetraacetic Acid (EDTA) in Phosphatase
Buffered Saline (PBS), avoiding single-cell suspensions. Medium
was changed every day. After two/three passages without or
with minimal spontaneous differentiation in feeder-dependent
conditions, cells were transferred to Matrigel (Corning)-coated
plates in mTeSR1 (STEMCELL Technologies) medium supple-
mented with 50 units/ml penicillin, 50 μg/ml streptomycin (Life
Technologies), using the same enzyme-free method. Medium
was changed every day. Cells were passaged at least twice in
feeder-free conditions before any experiment was performed.
DNA methylation analysis
Genomic DNA was purified using conventional phenol:
chloroform:isoamyl alcohol extraction. Bisulfite treatment was
performed using the EZ DNA Methylation Gold Kit (Zymo
Research) following manufacturer’s guidelines. Bisulfite treated
DNAwas amplified by PCR (MKRN3DMRandNDNDMR) or nested
PCR (PWS-IC and IG-DMR) using the primers and conditions
summarized in Supplementary Material, Table S1. For COBRA,
PCR products were extracted from the agarose gel using the
NZYGelpure kit (NZYTech) and then submitted to a restriction
digest with BstUI/Bsh1236I (Thermo Fisher) to distinguish
methylated from unmethylated alleles based on the original
status of the CGCG sequence. For bisulfite sequencing of the
PWS-IC and theMKRN3 DMR, PCR products were cloned into the
pGEM-T Easy vector (Promega) and at least 10 clones from each
sample were sequenced. Methylation analysis was performed
using BiQ Analyser (40).
RT-qPCR
Total RNA was isolated from fibroblasts, iPSCs and brain cortex
using NYZol (NZYtech) and then DNAse I treated (Roche) to
remove contaminating DNA. RNA template was reverse tran-
scribed using the Transcriptor High Fidelity cDNA Synthesis Kit
(Roche), according to the manufacturer’s instructions for RT-
qPCR. cDNA was subjected to qPCR with iTaqTM SYBR® Green
Supermix (Bio-Rad) in a ViiA7 Applied Biosystems machine,
according to the manufacturer’s instructions using the primers
in Supplementary Material, Table S2.
RT-PCR
cDNA was subjected to PCR to study MKRN3, NDN, MAGEL2 and
GAPDH expression. The primer pairs and PCR conditions are
described in Supplementary Material, Table S2.
Allelic-specific expression analysis
Primers were designed to amplify genomic regions around fre-
quent exonic SNPs in the human population for several genes
within chr15q11-q13 imprinted cluster (data not shown). SNPs
for SNRPN (rs705) and NDN (rs2192206) genes were found in the
Ctrl samples. cDNA collected from Ctrl FIBs and Ctrl A, Ctrl B,
Ctrl E and/or AS E iPSC samples were then amplified by PCR
and the product was sequenced to determine the monoallelic or
biallelic status of these genes. Primers for PCR and sequencing
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and respective PCR conditions are in Supplementary Material,
Table S2.
RNA FISH
In order to analyze UBE3A allelic-specific expression in Ctrl
FIBs, AS FIBs and Ctrl B, Ctrl E and AS E iPSCs, custom
StellarisTM RNA FISH probes designed using the StellarisTM
Probe Designer software (Biosearch Technologies). The dye
used was Quasar® 570 and the region used for the design of
the probe was Chr15:25353077-25360996 (GRCh38.p7). Probe
sequences are in Supplementary Material, Table S3. Cells were
cultured to 75% confluency and hybridization conditions for
RNA FISH were followed according to StellarisTM guidelines
using a final concentration of 125 nM of probe per cover-
slip.
For SNORD116 RNA FISH probe, a RP11-186C7 bacterial
artificial chromosome (BAC; BACPAC Resources Center) was
prepared using the Nick Translation Kit (Abbot) with Green
dUTP (Enzo Life Sciences). RNA FISH was done accordingly to
established protocols (41) in Ctrl B,Ctrl E andAS E iPSCs.After the
RNA FISH procedure for both probes, nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich), diluted
1:5000 in 2× Saline Sodium Citrate (SSC) buffer for 5 min
at room temperature (RT) and mounted with Vectashield
Mounting Medium (Vectorlabs). Cells were observed with the
widefield fluorescence microscope Zeiss Axio Observer (Carl
Zeiss MicroImaging) with 63× oil objective using the filter sets
FS43HE, FS38HE and FS49. Digital images were analyzed with
the FIJI platform (42). UBE3A and SNORD116 fluorescent signals
were counted in at least 64 cells of FIBs and at least 100 cells of
iPSCs.
IF
iPSCs were cultured in Matrigel-coated glass coverslips to 75%
confluency. Cells were washed with PBS and fixed with 3%
ParaFormAldehyde (PFA) for 10 min at RT, permeabilized with
0.5% Triton 100× (Sigma-Aldrich) in PBS on ice for 5 min and
incubated for 15 min at RT in blocking solution containing 1%
Bovine Serum Albumin (Sigma-Aldrich) in PBS. The cells were
stained with the primary antibody diluted in blocking solution
according to Supplementary Material, Table S4 for 45 min in a
humid chamber. Cells were then incubated with the secondary
antibody CyTM3 AffiniPure F(ab’)2 Fragment Goat Anti-Mouse
IgG (H+L) (dilution 1:200; Jackson ImmunoResearch Laboratories
Inc.) for 45 min. DAPI (0.2 mg/ml) was used to stain the DNA and
mark the nuclei by incubating at RT for 2 min. Mounting and
imaging was performed as stated for RNA FISH.
Karyotyping
iPSCs were expanded until they have reached the logarithmic
phase (70% confluency). Colcemid was added to the cell medium
at 10 μl/ml and cells were incubated in a humid incubator
at 37◦C with 5% (vol/vol) CO2 for 4 h. Cells were detached
with accutase, centrifuged at 300 g for 3 min and washed
with PBS three times. Cells were then incubated with 55 mm
of KCl at 37◦C for 30 min. After centrifugation for 15 min at
400 g, most of the supernatant was removed and only 1 ml
of supernatant was left for resuspending the cells. Fixative
solution (3:1 ratio of methanol:glacial acetic acid) was added
dropwise and the mixture was incubated on ice for 10 min.
After centrifugation at 400 g, most of the supernatant was
removed and only 1 ml of supernatant was left for resuspending
the cells. The steps of adding fixative solution, incubation on
ice and centrifugation were repeated three more times and
the nuclei were stored at −20◦C before G-banding karyotype
(performed by GenoMed, Diagnósticos de Medicina Molecular
SA).
Supplementary Material
Supplementary Material is available at HMG online.
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